Human Immunodeficiency Virus (1/2) Rapid Test Device (WB/S/P)

HIV stands for Human Immunodeficiency Virus, a virus that attacks the immune system and may lead to serious immune deficiency if untreated. HIV screening plays an important role in early diagnosis, treatment access, prevention support, and public health management.

• HIV screening helps identify infection early so individuals can receive appropriate medical support and counseling.
• Rapid HIV testing supports public health programs, antenatal care, blood safety, occupational health screening, and community healthcare campaigns.
• Many individuals with HIV may not show symptoms in the early stage, making routine screening important.
• Rapid HIV antibody screening can support faster healthcare decision-making and referral for confirmatory testing.

The HIV 1/2 Rapid Test Device by LARKSOIS Pharma may be used in professional diagnostic and healthcare screening environments.

Applications

• Hospital and diagnostic laboratory testing
• Public health HIV screening programs
• Community healthcare campaigns
• Blood bank screening support
• Pre-employment medical screening
• Pre-surgical screening support
• STI and infectious disease clinics
• Point-of-care diagnostic workflows
• International diagnostic distribution

• The HIV 1/2 Rapid Test Device works on the principle of lateral flow chromatographic immunoassay.
• When whole blood, serum, or plasma is added to the sample area, the specimen migrates across the membrane by capillary action.
• If antibodies to HIV-1 or HIV-2 are present, they bind with HIV antigen-coated reagents and produce a visible test line.
• The control line confirms proper sample migration and correct test performance.

The HIV 1/2 Rapid Test Device uses rapid lateral flow immunochromatographic technology for qualitative detection of HIV-1 and HIV-2 antibodies in whole blood, serum, or plasma specimens.

Benefits

• Rapid HIV antibody screening
• Qualitative detection of HIV-1 and HIV-2 antibodies
• Suitable for whole blood, serum, or plasma
• Simple visual interpretation
• Supports public health screening programs
• Useful for hospitals and laboratories
• Professional infectious disease application
• Practical point-of-care testing support

The HIV 1/2 Rapid Test Device is designed for whole blood, serum, or plasma specimens. Correct specimen collection and handling are important for reliable test performance.

Guidance

• Use approved whole blood, serum, or plasma specimens only
• Collect specimens according to the product insert
• Use clean and suitable sample collection materials
• Avoid contaminated or improperly stored samples
• Apply whole blood, serum, or plasma correctly to the sample well
• Add buffer as instructed
• Read results only within the recommended time window
• Handle all blood specimens as potentially infectious material

Note

Specimen collection, handling, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The HIV 1/2 Rapid Test Device by LARKSOIS Pharma is designed for qualitative detection of antibodies to HIV Type 1 and HIV Type 2 in whole blood, serum, or plasma specimens. Detection of HIV antibodies may indicate exposure to HIV and should be followed by confirmatory testing according to clinical guidelines.

• Rapid HIV screening supports early healthcare intervention and counseling.
• HIV antibody testing is important for public health programs and infection control workflows.
• A reactive HIV rapid test result should be followed by confirmatory laboratory testing according to national testing algorithms.
• Healthcare professionals should interpret results with exposure history, symptoms, patient risk profile, and laboratory recommendations.

The HIV 1/2 Rapid Test Device is a screening aid and should not be used as the only basis for diagnosis or treatment decisions. Results should be interpreted with clinical findings, exposure history, and confirmatory laboratory testing when required.

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood specimens as potentially infectious
• Wear gloves during sample handling
• Do not reuse the test device
• Avoid cross-contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Confirm reactive results where clinically required

Instructions

• Rapid HIV antibody screening
• Qualitative detection of HIV-1 and HIV-2 antibodies
• Suitable for whole blood, serum, or plasma
• Simple visual interpretation
• Supports public health screening programs
• Useful for hospitals, clinics, and laboratories
• Professional infectious disease application
• Practical point-of-care testing support

Note

The HIV 1/2 Rapid Test Device by LARKSOIS Pharma is designed for professional users who require practical and accessible HIV screening support.

Steps

• Bring the test device, sample, and buffer to room temperature
• Open the sealed pouch only when ready to test
• Place the test cassette on a clean and flat surface
• Add whole blood, serum, or plasma to the sample well
• Add buffer according to the instructions for use
• Wait for the recommended reaction time
• Read the test and control lines within the valid time window
• Do not interpret results after the recommended reading time
• Dispose of used materials according to laboratory safety procedures

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

A positive or reactive result means antibodies to HIV-1 or HIV-2 were detected. Confirmatory testing should be performed according to local HIV testing guidelines.

Negative

A negative result means HIV antibodies were not detected at the test’s detectable level. If recent exposure is suspected, repeat testing may be recommended after the window period.

Invalid

If the control line does not appear, the result is invalid and the test should be repeated with a new device according to the instructions for use.

Instructions

• Store the HIV 1/2 Rapid Test Device according to the product label and insert
• Store in a cool and dry place
• Keep sealed until use
• Protect from heat, sunlight, and moisture
• Do not freeze unless specified
• Do not use expired kits
• Use immediately after opening the pouch
• Follow all instructions for use carefully

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood specimens carefully
• Wear gloves during sample handling
• Do not reuse the test cassette
• Avoid specimen contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Confirm results with clinical evaluation when required

LARKSOIS Pharma provides internationally focused diagnostic products for healthcare professionals, laboratories, clinics, distributors, NGOs, public health programs, and medical procurement teams. The HIV 1/2 Rapid Test Device supports practical, fast, and reliable HIV screening workflows.

Advantages

• International infectious disease rapid test portfolio
• Reliable HIV screening solutions
• Suitable for hospitals, clinics, and laboratories
• Distributor-friendly product support
• Professional healthcare quality standards
• Practical point-of-care diagnostic format
• Export-ready diagnostic product positioning